Yamazaki Y, Ikeda M, Imada T, Furuno K, et al. A phase 3, multicenter, single-arm, open-label study to assess the safety, tolerability, and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese participants aged 6-64 years who are considered to be at increased ris Vaccine 2021 Sep 23. pii: S0264-410X(21)01168.
PMID: 34563397